Literature DB >> 33221767

Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.

Pei Xu1, Lei Wang1, Xiao Xie1, Fengqing Hu1, Qi Yang1, Rui Hu1, Lianyong Jiang1, Fangbao Ding1, Ju Mei1, Jianhui Liu2, Haibo Xiao1.   

Abstract

Accumulating studies suggest that circular RNAs (circRNAs) function as key regulators in human cancers. We found that hsa_circ_0001869 participated in non-small cell lung cancer (NSCLC) progression. However, its expression and function during NSCLC remain unknown. The data advised that hsa_circ_0001869 expression was increased in NSCLC cell lines and tissues. High hsa_circ_0001869 expression had negatively correlation with the NSCLC patients prognosis. Bioinformatics and luciferase report analyses confirmed that miR-638 and FOSL2 were hsa_circ_0001869 downstream target. hsa_circ_0001869 downregulation decreased tumor proliferation, invasion and migration by promoting miR-638 expression and decreasing FOSL2 expression. As a result of overexpression of FOSL2 or silencing of miR-638, the recovery of proliferation, migration, and invasion after hsa_circ_0001869 silencing. Overexpression of FOSL2 also led to recovery of migration, invasion and proliferation after upregulation of miR-638. In vivo studies confirmed that overexpression of FOSL2 or silencing of miR-638 led to the recovery of tumor growth ability regarding A549 cells after hsa_circ_0001869 knockdown. Present investigation discovered that hsa_circ_0001869 enhanced NSCLC progression via sponging miR-638 and promoting FOSL2 expression. hsa_circ_0001869 downregulation suppressed tumor growth and invasion ability.

Entities:  

Keywords:  FOSL2; NSCLC; hsa_circ_0001869; luciferin report analysis; miR-638

Mesh:

Substances:

Year:  2020        PMID: 33221767      PMCID: PMC7762492          DOI: 10.18632/aging.104037

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  30 in total

1.  Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.

Authors:  B Yan; W Zhang; X-W Mao; L-Y Jiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-12       Impact factor: 3.507

Review 2.  Emerging landscape of circular RNAs in lung cancer.

Authors:  Wei Hu; Zhuo-Yue Bi; Zhen-Long Chen; Cong Liu; Lin-Lin Li; Feng Zhang; Qun Zhou; Wei Zhu; Yang-Yi-Yan Song; Bo-Tao Zhan; Qian Zhang; Yong-Yi Bi; Cheng-Cao Sun; De-Jia Li
Journal:  Cancer Lett       Date:  2018-04-11       Impact factor: 8.679

3.  Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer.

Authors:  Fang Tian; C T Yu; W D Ye; Qian Wang
Journal:  Biochem Biophys Res Commun       Date:  2017-09-27       Impact factor: 3.575

4.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Reck; S Popat; N Reinmuth; D De Ruysscher; K M Kerr; S Peters
Journal:  Ann Oncol       Date:  2014-08-11       Impact factor: 32.976

5.  MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.

Authors:  H Wei; J-J Zhang; Q-L Tang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-12       Impact factor: 3.507

6.  Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer.

Authors:  Shuo Li; Xue-Dong Fang; Xiu-Ying Wang; Bing-Yuan Fei
Journal:  Exp Cell Res       Date:  2018-08-13       Impact factor: 3.905

7.  CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression.

Authors:  Yi-Bo Xue; Meng-Qi Ding; Lei Xue; Jin-Hua Luo
Journal:  Thorac Cancer       Date:  2019-06-27       Impact factor: 3.500

8.  The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.

Authors:  Siliang Wei; Yuanyuan Zheng; Yanru Jiang; Xiaojun Li; Jian Geng; Yuanbing Shen; Qin Li; Xiaojing Wang; Chengling Zhao; Yuqing Chen; Zhongqing Qian; Jihong Zhou; Wei Li
Journal:  EBioMedicine       Date:  2019-05-31       Impact factor: 8.143

9.  circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1.

Authors:  Zhuoan Cheng; Chengtao Yu; Shaohua Cui; Hui Wang; Haojie Jin; Cun Wang; Botai Li; Meilin Qin; Chen Yang; Jia He; Qiaozhu Zuo; Siying Wang; Jun Liu; Weidong Ye; Yuanyuan Lv; Fangyu Zhao; Ming Yao; Liyan Jiang; Wenxin Qin
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

10.  miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.

Authors:  Xiangran Sun; Guo Dai; Ling Yu; Qingzhu Hu; Jingteng Chen; Weichun Guo
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more
  7 in total

1.  Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.

Authors:  Yunzhong Liu; Shujun Wang; Songli Pan; Qingfeng Yan; Yueping Li; Ying Zhao
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 2.352

2.  Identification of a novel circular RNA circZNF652/miR-486-5p/SERPINE1 signaling cascade that regulates cancer aggressiveness in glioblastoma (GBM).

Authors:  Liang Liu; Shan Xiao; Yan Wang; Zifeng Zhu; Yiyao Cao; Sen Yang; Rongkang Mai; Yong Zheng
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

3.  SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.

Authors:  Zehua Bian; Mingyue Zhou; Kaisa Cui; Fan Yang; Yulin Cao; Shengbai Sun; Bingxin Liu; Liang Gong; Jiuming Li; Xue Wang; Chaoqun Li; Surui Yao; Yuan Yin; Shenglin Huang; Bojian Fei; Zhaohui Huang
Journal:  J Exp Clin Cancer Res       Date:  2021-11-15

4.  Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation.

Authors:  Rongzhen Ding; Lijing Jiao; Shuliu Sang; Yinan Yin; Yichao Wang; Yabin Gong; Ling Xu; Ling Bi
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-13       Impact factor: 2.629

5.  Circular RNA SOX13 promotes malignant behavior and cisplatin resistance in non-small cell lung cancer through targeting microRNA-3194-3p/microtubule-associated protein RP/EB family member 1.

Authors:  Libin Zhang; Hao Peng; Zheyuan Xu; Qiuju Yang; Yang Wang; Han Wang; Liang Bu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Circ_0078767 Inhibits the Progression of Non-Small-Cell Lung Cancer by Regulating the GPX3 Expression by Adsorbing miR-665.

Authors:  Xiting Liu; Ze Chen; Yuqiang Wu; Feng Gu; Dong Yan; Lei Yang; Qin Ma; Caihong Fu
Journal:  Int J Genomics       Date:  2022-03-17       Impact factor: 2.326

7.  Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.

Authors:  Yihong Wu; Jieyun Xie; Han Wang; Shufang Hou; Jiuhuan Feng
Journal:  J Clin Lab Anal       Date:  2022-04-08       Impact factor: 3.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.